Wieght Loss Drug May Help Coronary DIsease from Steven Nissen, MD

JAMA Report: Dr Steven Nissen, a cardiologist at the Cleveland Clinic, presents a study reported in JAMA that a new wieght loss drug may help patients with coronary artery disease. The drug, Rimonabant, is used in Europe, but not yet approved in the United States for weight loss. Although further studies are necessary, this study did show some benefit in patients with heart disease.

New Study-High Dose Vitamins Don't Slow Alzheimers from Paul Aisen, MD

JAMA Report: A new study looked at high dose vitamins and Alzheimer's disease. The study did show that the high dose vitamins did lower homocysteine levels, which is associated with Alzheimer's disease. However, having the lower levels of homocysteine did not tranlate into slowing of the disease progression in Alzheimers.

Breast Cancer Risk ongoing after stopping Hormones from Robert Wallace, MD

JAMA Report: THe womens health initiative was a major study which was halted after researchers found increased health risks in patients taking hormone replacement therapy. Now a new study in JAMA shows that the risk on breast cancer continues 3 years after stopping the medications.